Literature DB >> 15356105

Adoptive transfer of paternal antigen-hyporesponsive T cells induces maternal tolerance to the allogeneic fetus in abortion-prone matings.

Li-Ping Jin1, Da-Jin Li, Jin-Ping Zhang, Ming-Yan Wang, Xiao-Yong Zhu, Ying Zhu, Yi Meng, Min-Min Yuan.   

Abstract

The embryo expresses paternal Ags foreign to the mother and therefore has been viewed as an allograft. It has been shown that anergic T cells generated by blocking of the CD28/B7 costimulatory pathway with anti B7-1 and anti B7-2 mAbs can be transferred as suppresser cells to prevent allograft rejection. Little is known, however, about the in vivo function of anti-B7-treated T cells after their transfer into abortion-prone mice in the maintenance of materno-fetal tolerance. In the present study, abortion-prone CBA/J females mated with DBA/2 males were administered anti-B7-1 and anti-B7-2 mAbs on day 4 of gestation (murine implantation window). The anti-B7-treated T cells subsequently were adoptively transferred into abortion-prone CBA/J mice. We demonstrated that costimulation blockade with anti-B7 mAbs at the time of implantation resulted in altered allogeneic T cell response and overcame increased maternal rejection to the fetus in the CBA/JxDBA/2 system. The transferred anti-B7-treated T cells appeared to be regulatory, decreasing responsiveness and generating clonal deviation in maternal recipient T cells. The transferred CFSE-labeled T cells were found to reside in the spleen and uterine draining lymph nodes, and a few were localized to the materno-fetal interface of the maternal recipient. Our findings suggest that the anti-B7-treated T cells not only function as potent suppresser cells, but also exert an immunoregulatory effect on the maternal recipient T cells, which cosuppresses maternal rejection to the fetus. This procedure might be considered potentially useful for fetal survival when used as an immunotherapy for human recurrent spontaneous abortion. Copyright 2004 The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15356105     DOI: 10.4049/jimmunol.173.6.3612

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

Review 1.  B7 family molecules as regulators of the maternal immune system in pregnancy.

Authors:  Margaret G Petroff; Antoine Perchellet
Journal:  Am J Reprod Immunol       Date:  2010-04-08       Impact factor: 3.886

Review 2.  To drive or be driven: the path of a mouse model of recurrent pregnancy loss.

Authors:  Elizabeth A Bonney; Stephen A Brown
Journal:  Reproduction       Date:  2014-04-08       Impact factor: 3.906

3.  Human predecidual stromal cells are mesenchymal stromal/stem cells and have a therapeutic effect in an immune-based mouse model of recurrent spontaneous abortion.

Authors:  Raquel Muñoz-Fernández; Claudia De La Mata; Francisco Requena; Francisco Martín; Pablo Fernandez-Rubio; Tatiana Llorca; Maria José Ruiz-Magaña; Carmen Ruiz-Ruiz; Enrique G Olivares
Journal:  Stem Cell Res Ther       Date:  2019-06-14       Impact factor: 6.832

4.  Ex vivo generation of human alloantigen-specific regulatory T cells from CD4(pos)CD25(high) T cells for immunotherapy.

Authors:  Jorieke H Peters; Luuk B Hilbrands; Hans J P M Koenen; Irma Joosten
Journal:  PLoS One       Date:  2008-05-21       Impact factor: 3.240

5.  Alteration of Th17 and Treg cells in patients with unexplained recurrent spontaneous abortion before and after lymphocyte immunization therapy.

Authors:  Li Wu; Li-Hua Luo; Ying-Xin Zhang; Qing Li; Bo Xu; Gui-Xiang Zhou; Hong-Bing Luan; Yu-Sheng Liu
Journal:  Reprod Biol Endocrinol       Date:  2014-08-03       Impact factor: 5.211

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.